{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:01:30Z","timestamp":1788454890877,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011347","name":"University of Nevada Reno","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"UC Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jacep.2024.11.016","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T14:04:05Z","timestamp":1738159445000},"page":"708-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of the Membrane Environment on\u00a0Pharmacologic Inhibition of hERG K+ Channel Activity"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6191-8304","authenticated-orcid":false,"given":"Chase M.","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Vorobyov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen E.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.11.016_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A\u00a0mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.jacep.2024.11.016_bib2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacep.2024.11.016_bib3","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.hrthm.2010.09.017","article-title":"Early afterdepolarizations and cardiac arrhythmias","volume":"7","author":"Weiss","year":"2010","journal-title":"Heart Rhythm"},{"issue":"13","key":"10.1016\/j.jacep.2024.11.016_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2024.11.016_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A\u00a0new perspective in the field of cardiac safety testing through the comprehensive in\u00a0vitro proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"J\u00a0Biomol Screen"},{"issue":"8","key":"10.1016\/j.jacep.2024.11.016_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.119.316404","article-title":"A\u00a0computational pipeline to predict cardiotoxicity: from the atom to the rhythm","volume":"126","author":"Yang","year":"2020","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jacep.2024.11.016_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.jacep.2024.11.016_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1006\/jmcc.2000.1317","article-title":"I(Kr): the hERG channel","volume":"33","author":"Tseng","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacep.2024.11.016_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2015.05.009","article-title":"Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4","volume":"85","author":"Lees-Miller","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2024.11.016_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/mol.118.115642","article-title":"The pore-lipid interface: role of amino-acid determinants of lipophilic access by ivabradine to the hERG1 pore domain","volume":"96","author":"Perissinotti","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.jacep.2024.11.016_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1085\/jgp.201511470","article-title":"A\u00a0general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmics","volume":"146","author":"Rusinova","year":"2015","journal-title":"J\u00a0Gen Physiol"},{"issue":"Pt 17","key":"10.1016\/j.jacep.2024.11.016_bib12","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1113\/jphysiol.2010.191585","article-title":"Lipid microdomains and the regulation of ion channel function","volume":"588","author":"Dart","year":"2010","journal-title":"J\u00a0Physiol"},{"issue":"2-3","key":"10.1016\/j.jacep.2024.11.016_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pbiomolbio.2009.01.012","article-title":"Caveolae, ion channels and cardiac arrhythmias","volume":"98","author":"Balijepalli","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"10.1016\/j.jacep.2024.11.016_bib14","doi-asserted-by":"crossref","first-page":"C74","DOI":"10.1152\/ajpcell.00462.2009","article-title":"Ceramide modulates HERG potassium channel gating by translocation into lipid rafts","volume":"299","author":"Ganapathi","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.jacep.2024.11.016_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/chan.25122","article-title":"Cholesterol regulates HERG K+ channel activation by increasing phospholipase C \u03b21 expression","volume":"7","author":"Chun","year":"2013","journal-title":"Channels (Austin)"},{"issue":"4","key":"10.1016\/j.jacep.2024.11.016_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/chan.4946","article-title":"Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol","volume":"1","author":"Balijepalli","year":"2007","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.jacep.2024.11.016_bib17","first-page":"1","article-title":"Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012","volume":"177","author":"Gu","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.jacep.2024.11.016_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.RES.82.3.386","article-title":"Molecular determinants of dofetilide block of HERG K+ channels","volume":"82","author":"Ficker","year":"1998","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jacep.2024.11.016_bib19","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0022-2275(20)34940-3","article-title":"Use of cyclodextrins for manipulating cellular cholesterol content","volume":"38","author":"Christian","year":"1997","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacep.2024.11.016_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.yjmcc.2010.11.015","article-title":"Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes","volume":"50","author":"Agarwal","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2024.11.016_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.104.000117","article-title":"Structural determinants of HERG channel block by clofilium and ibutilide","volume":"66","author":"Perry","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.jacep.2024.11.016_bib22","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.CIR.91.6.1799","article-title":"Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects","volume":"91","author":"Yang","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.016_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","article-title":"Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent: specific block of rapidly activating delayed rectifier K+ current by dofetilide","volume":"72","author":"Jurkiewicz","year":"1993","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jacep.2024.11.016_bib24","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.94.10.2572","article-title":"Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide","volume":"94","author":"Kiehn","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2024.11.016_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/PL00005344","article-title":"Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels","volume":"359","author":"Kiehn","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jacep.2024.11.016_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(97)00114-4","article-title":"Cellular electropharmacology of amiodarone","volume":"35","author":"Kodama","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.jacep.2024.11.016_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2828(88)80128-7","article-title":"Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone","volume":"20","author":"Herbette","year":"1988","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2024.11.016_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14656566.2011.548321","article-title":"Ivabradine: recent and potential applications in clinical practice","volume":"12","author":"Riccioni","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.jacep.2024.11.016_bib29","article-title":"hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine","volume":"4","author":"Melgari","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2024.11.016_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fphar.2020.00914","article-title":"Allosteric coupling between drug binding and the aromatic cassette in the pore domain of the hERG1 channel: implications for a state-dependent blockade","volume":"11","author":"Kudaibergenova","year":"2020","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.jacep.2024.11.016_bib31","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1248\/cpb.59.1110","article-title":"A\u00a0risk assessment of human ether-a-go-go-related gene potassium channel inhibition by using lipophilicity and basicity for drug discovery","volume":"59","author":"Kawai","year":"2011","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"6","key":"10.1016\/j.jacep.2024.11.016_bib32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bmcl.2006.12.061","article-title":"A\u00a0quantitative assessment of hERG liability as a function of lipophilicity","volume":"17","author":"Waring","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"10.1016\/j.jacep.2024.11.016_bib33","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/jm900002x","article-title":"Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers","volume":"52","author":"Zachariae","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jacep.2024.11.016_bib34","article-title":"Estimation of the in\u00a0vivo release of amiodarone from the pharmacokinetics of its active metabolite and correlation with its in\u00a0vitro release","volume":"11","author":"Shleghm","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jacep.2024.11.016_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/24734306.2022.2031565","article-title":"Lipid emulsion mitigates intravenous amiodarone toxicity in a rat model","volume":"6","author":"Stewart","year":"2022","journal-title":"Toxicol Commun"},{"issue":"5","key":"10.1016\/j.jacep.2024.11.016_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1085\/jgp.200308996","article-title":"Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol","volume":"123","author":"Lundbaek","year":"2004","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jacep.2024.11.016_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2016.05.013","article-title":"Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking","volume":"113","author":"Zhang","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.jacep.2024.11.016_bib38","article-title":"Direct and indirect cholesterol effects on membrane proteins with special focus on potassium channels","volume":"1865","author":"Zakany","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"10.1016\/j.jacep.2024.11.016_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"issue":"1-2","key":"10.1016\/j.jacep.2024.11.016_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0270(98)00019-3","article-title":"Identification of endogenous outward currents in the human embryonic kidney (HEK 293) cell line","volume":"81","author":"Zhu","year":"1998","journal-title":"J\u00a0Neurosci Methods"},{"issue":"5","key":"10.1016\/j.jacep.2024.11.016_bib41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.RES.81.5.870","article-title":"Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current","volume":"81","author":"London","year":"1997","journal-title":"Circ Res"},{"issue":"52","key":"10.1016\/j.jacep.2024.11.016_bib42","doi-asserted-by":"crossref","first-page":"21548","DOI":"10.1074\/jbc.M117.816488","article-title":"hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels","volume":"292","author":"McNally","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacep.2024.11.016_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fphys.2018.00207","article-title":"Determinants of isoform-specific gating kinetics of hERG1 channel: combined experimental and simulation study","volume":"9","author":"Perissinotti","year":"2018","journal-title":"Front Physiol"},{"issue":"2b","key":"10.1016\/j.jacep.2024.11.016_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.2011.01378.x","article-title":"hERG subunit composition determines differential drug sensitivity","volume":"164","author":"Abi-Gerges","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.jacep.2024.11.016_bib45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","article-title":"Statin effects on cholesterol micro-domains in brain plasma membranes","volume":"65","author":"Kirsch","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"21 Suppl 1","key":"10.1016\/j.jacep.2024.11.016_bib46","first-page":"ii34","article-title":"Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress","volume":"109","author":"Mason","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2024.11.016_bib47","article-title":"Long QT: time to cut cholesterol?","volume":"45","author":"Li","year":"2023","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24010223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:46:14Z","timestamp":1775022374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24010223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2405500X24010223"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.11.016","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the Membrane Environment on\u00a0Pharmacologic Inhibition of hERG K+ Channel Activity","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}